ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026
Assessing the annual burden of tick-borne encephalitis virus infections, north-east Italy, 2017 to 2024.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUNDTick-borne encephalitis (TBE), a neuroinvasive disease in humans, is endemic in north-east Italy and nationally notifiable since 2017. Domestic TBE incidence, although low, has increased in recent years while TBE vaccination coverage remains < 10%.AIMWe aimed to estimate the burden of TBE virus (TBEV) infections in north-east Italy (Triveneto) in 2017-2024.METHODSWe estimated disability-adjusted life years (DALYs) with 95% uncertainty intervals (UI) using the Burden of Communicable Diseases in Europe software. Input data included TBE cases notified in 2017-2024 with residence and/or infection or exposure in Triveneto (autonomous provinces (AP) of Trento and Bolzano and regions of Veneto and Friuli-Venezia Giulia) and correction factors for TBE underdiagnosis and TBEV infection under-ascertainment.RESULTSIn 2017-2024, 295 TBE cases were notified in Triveneto. The mean annual burden of TBEV infections was estimated at 0.58 (95% UI: 0.55-0.62) DALYs per 100,000 population. Estimates were highest in 2022 (1.07; 95% UI: 1.00-1.14 DALYs/100,000). The areas with the highest burden were Belluno province (4.17; 95% UI: 3.88-4.46 DALYs/100,000/year) and the AP of Trento (2.84; 95% UI: 2.65-3.05 DALYs/100,000/year). Males accounted for 67.0% of DALYs. All age groups experienced on average ≤ 1 DALYs per 100,000 population per year.CONCLUSIONThe burden of TBEV infections in north-east Italy is relatively low and with an uneven geographical distribution. Increasing TBE vaccination coverage across age groups, prioritising elevated impact areas, may reduce the burden of TBEV infections in north-east Italy and maintain TBE as a low-burden disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.